Brief: Lunai Bioworks (Nasdaq Lnai) Launches Ai Oncology Pilot
09/02/2026 14:40
Feb 9 (Reuters) - Lunai Bioworks Inc LNAI.O: LUNAI BIOWORKS (NASDAQ: LNAI) LAUNCHES AI ONCOLOGY PILOT WITH CLINICAL-STAGE PARTNER TO ANALYZE RANDOMIZED PHASE 2 METASTATIC COLORECTAL CANCER SURVIVAL TRIAL DATA Source text: ID:nPn41VZrba Further company coverage: LNAI.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lunai Bioworks
See all newsNASDAQ RESUMED AT 02:16 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 02:06 PM
Brief: Lunai Bioworks Expands Parkinson's Platform Through Exclusive Tanaist Agreement
Brief: Lunai Bioworks Signs Agreement With Brainstorm Therapeutics
Brief: Lunai Bioworks - Regains Nasdaq Compliance With Minimum $1 Bid Price Rule - SEC Filing